Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS)

BACKGROUND: Intrathecal baclofen (ITB) is a treatment option for patients with severe poststroke spasticity (PSS) who have not reached their therapy goal with other interventions. METHODS: ’Spasticity In Stroke–Randomised Study' (SISTERS) was a randomised, controlled, open-label, multicentre ph...

Descripción completa

Detalles Bibliográficos
Autores principales: Creamer, Michael, Cloud, Geoffrey, Kossmehl, Peter, Yochelson, Michael, Francisco, Gerard E, Ward, Anthony B, Wissel, Jörg, Zampolini, Mauro, Abouihia, Abdallah, Berthuy, Nathalie, Calabrese, Alessandra, Loven, Meghann, Saltuari, Leopold
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Cerebrovascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031277/
https://www.ncbi.nlm.nih.gov/pubmed/29326296
http://dx.doi.org/10.1136/jnnp-2017-317021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031277/
https://www.ncbi.nlm.nih.gov/pubmed/29326296
http://dx.doi.org/10.1136/jnnp-2017-317021

Ejemplares similares